Viewing Study NCT02524392


Ignite Creation Date: 2025-12-24 @ 3:17 PM
Ignite Modification Date: 2026-01-16 @ 6:39 AM
Study NCT ID: NCT02524392
Status: COMPLETED
Last Update Posted: 2018-05-11
First Post: 2015-06-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect Evaluation of Independent Medical Evaluation (IME) in Norway
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'interventionBrowseModule': {'meshes': [{'id': 'D000070536', 'term': 'Independent Medical Evaluation'}], 'ancestors': [{'id': 'D017531', 'term': 'Health Care Evaluation Mechanisms'}, {'id': 'D011787', 'term': 'Quality of Health Care'}, {'id': 'D017530', 'term': 'Health Care Quality, Access, and Evaluation'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'HEALTH_SERVICES_RESEARCH', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 7642}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2015-09', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2018-05', 'completionDateStruct': {'date': '2018-03', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2018-05-09', 'studyFirstSubmitDate': '2015-06-23', 'studyFirstSubmitQcDate': '2015-08-13', 'lastUpdatePostDateStruct': {'date': '2018-05-11', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2015-08-14', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2018-02', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Change in sick leave', 'timeFrame': 'Measured at three and eight weeks after randomization.', 'description': 'Data on sickness benefits from official registers will be used to measure the primary outcome.'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['independent medical evaluation', 'sick leave', 'sickness absence', 'physician primary care', 'general practitioner', 'family physician'], 'conditions': ['All International Classification of Primary Care 2 Diagnoses']}, 'referencesModule': {'references': [{'pmid': '35216560', 'type': 'DERIVED', 'citation': 'Maeland S, Holmas TH, Oyeflaten I, Husabo E, Werner EL, Monstad K. What is the effect of independent medical evaluation on days on sickness benefits for long-term sick listed employees in Norway? A pragmatic randomised controlled trial, the NIME-trial. BMC Public Health. 2022 Feb 26;22(1):400. doi: 10.1186/s12889-022-12800-1.'}, {'pmid': '32193258', 'type': 'DERIVED', 'citation': "Oyeflaten I, Maeland S, Haukenes I. Independent medical evaluation of general practitioners' follow-up of sick-listed patients: a cross-sectional study in Norway. BMJ Open. 2020 Mar 18;10(3):e032776. doi: 10.1136/bmjopen-2019-032776."}, {'pmid': '30157844', 'type': 'DERIVED', 'citation': 'Aamland A, Husabo E, Maeland S. Independent medical evaluation for sick-listed patients: a focus group study of GPs expectations and experiences. BMC Health Serv Res. 2018 Aug 29;18(1):666. doi: 10.1186/s12913-018-3481-3.'}, {'pmid': '28615017', 'type': 'DERIVED', 'citation': 'Husabo E, Monstad K, Holmas TH, Oyeflaten I, Werner EL, Maeland S. Protocol for the effect evaluation of independent medical evaluation after six months sick leave: a randomized controlled trial of independent medical evaluation versus treatment as usual in Norway. BMC Public Health. 2017 Jun 14;17(1):573. doi: 10.1186/s12889-017-4469-3.'}]}, 'descriptionModule': {'briefSummary': 'A randomized controlled trial comparing independent medical evaluation (IME) to treatment as usual (TAU). Participants will be individuals reaching six months uninterrupted sickness absence. Treatment as usual (TAU) is normal follow-up by a general practitioner (GP).', 'detailedDescription': 'A randomized controlled trial in a Norwegian context, involving an effect evaluation, a cost-benefit evaluation and a qualitative evaluation. Independent medical evaluation (IME) will be compared to treatment as usual (TAU). Independent medical evaluation (IME) will comprise a consultation with an independent general practitioner (IME GP) who will assess whether the sick listed worker has been given eligible and available opportunities in return to work follow-up in Norway. The independent medical evaluation general practitioner (IME GP) will write a short report that is sent to the treating general practitioner as input from a colleague. The report can be used in the follow-up of the sick listed participant. The participants in the treatment as usual (TAU) group will not receive any other follow-up than normal follow-up by the treating general practitioner. The qualitative evaluation will be conducted to gain insight into the experiences of the general practitioners and the participants.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '66 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* Participants on sick leave with an International Classification of Primary Care-2 diagnosis will be recruited through the Norwegian Labour and Welfare Administration's (NAV) registries, when reaching 22 weeks of sick leave (full or graded).\n\nExclusion Criteria:\n\n* People with International Classification of Disease-10 diagnoses, cancer or dementia.\n* People who are pregnant."}, 'identificationModule': {'nctId': 'NCT02524392', 'acronym': 'NIME', 'briefTitle': 'Effect Evaluation of Independent Medical Evaluation (IME) in Norway', 'organization': {'class': 'OTHER', 'fullName': 'NORCE Norwegian Research Centre AS'}, 'officialTitle': 'Effect Evaluation of Independent Medical Evaluation (IME) After Six Months Sick Leave: A Randomized Controlled Trial of Independent Medical Evaluation (IME) Versus Treatment as Usual in Norway', 'orgStudyIdInfo': {'id': 'UniResearch'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Independent medical evaluation', 'description': 'Independent medical evaluation (IME) of another doctor than the treating general practitioner.', 'interventionNames': ['Other: Independent medical evaluation']}, {'type': 'NO_INTERVENTION', 'label': 'Treatment as usual', 'description': 'Treatment as usual by the treating general practitioner. There will be one randomized control group in one county. Sick-listed in other counties serve as an extra control group.'}], 'interventions': [{'name': 'Independent medical evaluation', 'type': 'OTHER', 'description': 'The independent medical evaluation (IME) will be performed by specialists in general medicine, temporarily hired by the county welfare service. The independent medical evaluation (IME) procedure is developed by the Research Unit for General Practice at Uni Research Health in Norway.', 'armGroupLabels': ['Independent medical evaluation']}]}, 'contactsLocationsModule': {'locations': [{'zip': '5014', 'city': 'Bergen', 'country': 'Norway', 'facility': 'Uni Research', 'geoPoint': {'lat': 60.39299, 'lon': 5.32415}}], 'overallOfficials': [{'name': 'Silje Maeland, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Uni Research Health'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'NORCE Norwegian Research Centre AS', 'class': 'OTHER'}, 'collaborators': [{'name': 'Norwegian Labour and Welfare Administration', 'class': 'OTHER'}], 'responsibleParty': {'type': 'SPONSOR'}}}}